Shares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a move attributed to a potential market launch of a rival kidney disease therapy from Otsuka Holdings ...

Louise has shared details of a new album called ‘Confessions’. Find out more and check out the lead single below. Set for release on May 23, the new record will mark the fifth studio album ...

On behalf of the United States of America, I extend warm wishes to President Mahama and the people of Ghana as they celebrate their National Day. The U.S. partnership with Ghana - rooted in our ...

Vera Wang continues to stun on the red carpet. The fashion designer showed off her ageless beauty on the BAFTA Awards 2025 red carpet Sunday, wearing a Haute Couture gown of her own design that ...

Goldman Sachs notes that Vera Therapeutics (VERA) shares are down 18% and underperforming the biotech group today following earnings results from Otsuka that included a comment on potential at ...

Just over a month since tears were shed over the end of Vera, a choked up Brenda Blethyn had the crowd on their feet at the Royal Television Awards in Gateshead on Saturday night, as she took home ...

Vera Wang once again proved she’s aging backwards as she hit the red carpet at the 2025 BAFTAs in London Sunday night. The fashion designer, 75, posed for photos at London’s Royal Festival ...

Kenny Doughty, known for his role as DC Aiden Healy in the acclaimed series Vera, recently shared a moment he was left 'starstruck' during his early acting days. The actor, 49, is poised to grace ...

Her work has previously appeared in The Zoe Report, Popsugar, Insider and more. Vera Wang never fails to deliver a jaw-dropping red carpet moment. On Sunday, Feb. 16, the fashion designer ...

FILE - Speaker of Ghana Parliament Alban Sumana Bagbin speaks at the Parliament House in Accra, Wednesday, Feb. 28, 2024. (AP Photo/Misper Apawu, file) 37,094 people played the daily Crossword ...

Investing.com -- Shares of Vera Therapeutics Inc. (NASDAQ: VERA) tumbled by 17% as the market responded to updates on a competing drug that could challenge the company's position in the IgAN market.